Jared Bieniek, MD
Urology · Hartford, CTNPI 1982846457
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (53.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Acerus Pharmaceuticals Corporation at 52.8% of the total. Reporting peaked in 2022 at $4,790 and has fallen 90.1% since, to $472 in 2025.
Across 66 payments — averaging $133.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acerus Pharmaceuticals Corporation$5K
- Boston Scientific$3K
- Coloplast$1K
- Olympus America Inc.$131
- Antares Pharma, Inc.$100
- Pfizer$29
- plus $52 from 2 others
What the payments were for
- Consulting fees$4,70053%
- Speaking & faculty fees$1662%
- Travel & lodging$1,44216%
- Food & beverage$2,48628%
- Education$290%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acerus Pharmaceuticals Corporation | 7 | $4,658 |
| Boston Scientific | 38 | $2,795 |
| Coloplast | 14 | $1,058 |
| Olympus America Inc. | 1 | $131 |
| Antares Pharma, Inc. | 2 | $100 |
| Pfizer | 2 | $29 |
| Axonics, Inc. | 1 | $28 |
| Laborie Medical Technologies Corp. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Natesto$4,503
- AMS$881
- TITAN$791
- Olympus Cysto-Resection$131
- AMS 700$116
How this compares
$8,823 in reported general payments places this provider in the 80th percentile of 156 urology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 45 | $29,527 |
| MyrbetriqMirabegron | 18 | $16,776 |
| Testosterone | 64 | $8,572 |
| Tamsulosin Hcl | 364 | $6,454 |
| Tadalafil | 22 | $2,778 |
| Potassium Citrate ErPotassium Citrate | 19 | $2,295 |
| Finasteride | 157 | $1,490 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 65 | $1,316 |
| Testosterone Cypionate | 43 | $1,308 |
| Dutasteride | 11 | $261 |
| Oxybutynin Chloride ErOxybutynin Chloride | 21 | $228 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $123 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 19 | $107 |
| Cephalexin | 14 | $84 |
| Meloxicam | 15 | $49 |
Paid to pharmacies, not to this prescriber.
Other urology in Hartford
- Steven ShichmanHartford$28K
- Joseph WagnerHartford$21K
- Eric KatzHartford$14K
- Shanta ShepherdHartford$8K
- Christine CumarasamyHartford$6K
- Guy TronoHartford$6K
- Abram DamatoHartford$6K
- Peter BoscoHartford$3K
- Aaron TurnquistHartford$3K
- Daniel KellnerNew Haven$122K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.